RxDoctor Payments Data

Susan Childress, MD

Rheumatology · Englewood, CONPI 1235229915

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,734 of the $1,830 with a category attached, or 94.8%. Eli Lilly accounts for 99.9% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for rheumatology clinicians in CO, where the typical reported total is $1,681.

$1,830in general payments, 2019–2025

Across 17 payments — averaging $107.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$2K
  • Lilly USA, LLC$1
$352,105in research payments, 2019–2025

Across 82 payments — averaging $4293.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • EMD Serono, Inc.$87K
  • Janssen Research & Development, LLC$76K
  • AbbVie$67K
  • Bristol Myers Squibb$61K
  • Amgen$58K
  • Eli Lilly$2K

What the payments were for

  • Travel & lodging$1,73495%
  • Food & beverage$955%
  • Education$10%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly16$1,829
Lilly USA, LLC1$1

How this compares

$1,830 in reported general payments places this provider in the 50th percentile of 108 rheumatology providers in Colorado.

See all rheumatology providers in Colorado

Medicare billing

Part B allowed, 2024
$16,690
Medicare patients
56
Services billed
143

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab19$148,277
Hydroxychloroquine Sulfate58$1,793
Colchicine15$1,026
MethotrexateMethotrexate Sodium58$999
Prednisone83$425
Folic Acid13$61
Allopurinol14$43

Paid to pharmacies, not to this prescriber.

Other rheumatology in Englewood

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →